E08.59 coverage policies: Medicare and commercial payers

68 active Medicare policies list E08.59, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for E08.59

Free account. Policy pages stay open to everyone.

Medicare policies listing E08.59

LCD · WPS-J5-L35490

Category III Codes

J5 · Effective Oct 1, 2015

LCD · WPS-J8-L35490

Category III Codes

J8 · Effective Oct 1, 2015

LCD · CGS-J15-L38662

Implantable Continuous Glucose Monitors (I-CGM)

J15 · Effective Nov 2, 2020

LCD · FIRST_COAST-L38664

Implantable Continuous Glucose Monitors (I-CGM)

J9 · Effective Oct 11, 2020

LCD · NGS-J6-L38623

Implantable Continuous Glucose Monitors (I-CGM)

J6 · Effective Dec 1, 2020

LCD · NGS-JK-L38623

Implantable Continuous Glucose Monitors (I-CGM)

JK · Effective Dec 1, 2020

LCD · NORIDIAN-JE-L38657

Implantable Continuous Glucose Monitors (I-CGM)

JE · Effective Nov 2, 2020

LCD · NORIDIAN-JF-L38657

Implantable Continuous Glucose Monitors (I-CGM)

JF · Effective Nov 2, 2020

LCD · NOVITAS-JH-L38617

Implantable Continuous Glucose Monitors (I-CGM)

JH · Effective Oct 11, 2020

LCD · NOVITAS-JL-L38617

Implantable Continuous Glucose Monitors (I-CGM)

Commercial payer policies listing E08.59

1 policy from 1 payer

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Anthem

Anthem policies listing E08.59, with the code’s status in each
Policy	Effective	Status of E08.59
Therapeutic use of Stem Cells, Blood and Bone Marrow ProductsPayerPolicy · ANTHEM-TRANS.00035	Oct 1, 2026	Not covered